MATURE B-CELL MALIGNANCIES
Clinical trials for MATURE B-CELL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new MATURE B-CELL MALIGNANCIES trials appear
Sign up with your email to follow new studies for MATURE B-CELL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for blood cancer patients
Disease control OngoingThis early-phase study tests a new drug called BGB-11417 (sonrotoclax) in people with B-cell blood cancers that have come back or not responded to treatment. The goal is to find the safest dose and see how well it works alone or combined with other drugs. About 437 adults will ta…
Matched conditions: MATURE B-CELL MALIGNANCIES
Phase: PHASE1 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New pill shows promise for tough blood cancers in early trial
Disease control OngoingThis early-stage study tests a new drug, BGB-11417, in 64 adults with B-cell blood cancers that have come back or not responded to prior treatments. The main goals are to find the safest dose and understand side effects. Researchers will also look for signs that the drug shrinks …
Matched conditions: MATURE B-CELL MALIGNANCIES
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC